Reference
- Calzolari F, et al. Security profile of biological therapy: Infliximab and adalimumab, a comparison. Digestive and Liver Disease 46 (Suppl. 3): e92-e93, 30 Sep 2014. Available from: URL: http://doi.org/10.1016/j.dld.2014.07.073 [abstract] - ItalyCrossRefGoogle Scholar
Copyright information
© Springer International Publishing Switzerland 2014